Treatment Outcomes in Anaplastic Thyroid Cancer

BACKGROUND: Anaplastic thyroid cancer (ATC) is rare, accounting for 1-2% of thyroid malignancies. Median survival is only 3-10 months, and the optimal therapeutic approach has not been established. This study aimed to evaluate outcomes in ATC based on treatment modality. METHODS: Retrospective revie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thyroid Res
Main Authors: Corrigan, Kelsey L., Williamson, Hannah, Elliott Range, Danielle, Niedzwiecki, Donna, Brizel, David M., Mowery, Yvonne M.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556325/
https://ncbi.nlm.nih.gov/pubmed/31249658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8218949
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados